Literature DB >> 34063903

Solubility Enhancement of Ibuprofen by Adsorption onto Spherical Porous Calcium Silicate.

Yayoi Kawano1, Shiyang Chen1, Takehisa Hanawa1.   

Abstract

The solubility of a drug is higher when it is in an amorphous form than when it is in a crystalline form. To enhance the solubility of ibuprofen (IBU), a poorly water-soluble drug, we attempted to adsorb IBU onto spherical porous calcium silicate (Florite® PS300, PS300) in two ways: the evaporation (EV) and sealed heating (SH) methods. The crystallinity of the samples was evaluated using powder X-ray diffraction analysis (PXRD) and differential scanning calorimetry (DSC). The molecular interaction between IBU and PS300 was evaluated with FTIR. In addition, the dissolution behavior of IBU in the samples was assessed by the dissolution test. Based on the results of the PXRD and DSC measurements, both methods allowed adsorption of IBU onto PS300, and IBU was amorphized. Based on the FTIR observations, in the SH or EV mixtures containing 10% and 30% IBU, respectively, it seemed that the IBU molecules intermolecularly interacted with calcium molecules as the main component of PS300. Improvement in the solubility of IBU was observed with both methods; however, the dissolution rate of IBU from samples prepared via SH was higher than that from EV, or of IBU crystals. Collectively, our findings indicate that the petal-like structure of PS300, which has a spherical shape and good flowability, is an effective tool for adsorbing IBU onto PS300 via SH.

Entities:  

Keywords:  amorphous; evaporation; ibuprofen; sealed heating; spherical calcium silicate; sublimation

Year:  2021        PMID: 34063903     DOI: 10.3390/pharmaceutics13060767

Source DB:  PubMed          Journal:  Pharmaceutics        ISSN: 1999-4923            Impact factor:   6.321


  35 in total

Review 1.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

Authors:  C A Lipinski; F Lombardo; B W Dominy; P J Feeney
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

Review 2.  Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

Authors:  R H Müller; C Jacobs; O Kayser
Journal:  Adv Drug Deliv Rev       Date:  2001-03-23       Impact factor: 15.470

3.  Micronization of drugs using supercritical carbon dioxide.

Authors:  J Kerc; S Srcic; Z Knez; P Sencar-Bozic
Journal:  Int J Pharm       Date:  1999-05-10       Impact factor: 5.875

4.  Selection of excipient, solvent and packaging to optimize the performance of spray-dried formulations: case example fenofibrate.

Authors:  Marc Hugo; Klaus Kunath; Jennifer Dressman
Journal:  Drug Dev Ind Pharm       Date:  2012-05-17       Impact factor: 3.225

Review 5.  Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.

Authors:  Yohei Kawabata; Koichi Wada; Manabu Nakatani; Shizuo Yamada; Satomi Onoue
Journal:  Int J Pharm       Date:  2011-08-30       Impact factor: 5.875

6.  Improvement of solubility and oral bioavailability of a poorly water-soluble drug, TAS-301, by its melt-adsorption on a porous calcium silicate.

Authors:  Masahiro Kinoshita; Kazuhiko Baba; Atushi Nagayasu; Kanoo Yamabe; Takashi Shimooka; Yoh'ichiro Takeichi; Mami Azuma; Hitoshi Houchi; Kazuo Minakuchi
Journal:  J Pharm Sci       Date:  2002-02       Impact factor: 3.534

7.  Crystal engineering of novel cocrystals of a triazole drug with 1,4-dicarboxylic acids.

Authors:  Julius F Remenar; Sherry L Morissette; Matthew L Peterson; Brian Moulton; J Michael MacPhee; Héctor R Guzmán; Orn Almarsson
Journal:  J Am Chem Soc       Date:  2003-07-16       Impact factor: 15.419

8.  Application of calcium silicate for medicinal preparation. I. Solid preparation adsorbing an oily medicine to calcium silicate.

Authors:  H Yuasa; D Asahi; Y Takashima; Y Kanaya; K Shinozawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1994-11       Impact factor: 1.645

9.  Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process.

Authors:  Jeong-Soo Kim; Min-Soo Kim; Hee Jun Park; Shun-Ji Jin; Sibeum Lee; Sung-Joo Hwang
Journal:  Int J Pharm       Date:  2008-04-12       Impact factor: 5.875

10.  Racemic species of sodium ibuprofen: characterization and polymorphic relationships.

Authors:  Geoff G Z Zhang; Sophia Y L Paspal; Raj Suryanarayanan; David J W Grant
Journal:  J Pharm Sci       Date:  2003-07       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.